[Sensitivity and specificity of lead poisoning detection tests]. 1982

S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier

The results of biochemical tests used for the supervision of factory workers exposed to lead (notably lead serum levels, urinary aminolevulinic acid (ALA) and punctuated red cells) were compared in 90 patients. The reference test used to evaluate the sensitivity and specificity of these examinations was EDTA-induced lead urinary excretion. Lead serum levels and urinary ALA were about equally effective in providing information. However, these two tests were more sensitive when performed simultaneously than when performed separately. It is suggested that both should be requested when trying to prevent lead poisoning.

UI MeSH Term Description Entries
D007854 Lead A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.2, symbol Pb.
D007855 Lead Poisoning Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of LEAD or lead compounds. Poisoning, Lead,Lead Poisonings,Poisonings, Lead
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000622 Aminolevulinic Acid A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. 5-Amino Levulinic Acid,5-Aminolaevulinate,5-Aminolevulinate,Aminolevulinic Acid Hydrochloride,Delta-Aminolevulinic Acid,Levulan,5 Amino Levulinic Acid,5 Aminolaevulinate,5 Aminolevulinate,Acid Hydrochloride, Aminolevulinic,Acid, 5-Amino Levulinic,Acid, Aminolevulinic,Acid, Delta-Aminolevulinic,Delta Aminolevulinic Acid,Hydrochloride, Aminolevulinic Acid,Levulinic Acid, 5-Amino

Related Publications

S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
December 1971, The New England journal of medicine,
S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
August 1984, Cardiology clinics,
S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
January 1969, Arhiv za higijenu rada i toksikologiju,
S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
December 1974, Virginia medical monthly,
S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
January 1980, Laboratornoe delo,
S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
September 1985, Revue medicale de Bruxelles,
S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
October 1991, American journal of clinical pathology,
S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
January 1981, Giornale italiano di cardiologia,
S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
August 2012, Phlebology,
S Dally, and A Bensaid, and A Buisine, and G Thomas, and E Fournier
June 1994, BMJ (Clinical research ed.),
Copied contents to your clipboard!